NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/14/2024
Back to search
Official data from USPTO
MEDILINK
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
05/14/2024
Trademark type
Combined
Nice classes
42
Filing date
01/20/2022
Registration date
05/14/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/14/2024
Last transaction
05/14/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
06/30/2020
First use in commerce
06/30/2020
Drawing code
5
Owner type
99
Owner location
Suzhou, Jiangsu, CN
Examiner
KRUSSMAN, IAN GEORGE
Law office
N80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "MEDILINK".
Holders and representatives
Holders
MediLink Therapeutics(Suzhou)Co.,Ltd.
Representatives
Timothy T. Wang NI, WANG & MASSAND, PLLC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Biochemical research and development; Biomedical research services; Biotechnology research; Chemical research; Chemical research and analysis; Chemistry consultation; Development and test of chemical production methods; Development of pharmaceutical preparations and medicines; Medical and scientific researchconducting clinical trials for others; Pharmaceutical research and development; Professional consulting services and advice about agricultural chemistry; Research and development in the field of antibody-drug conjugates; Research and development in the field of antibody conjugates; Research and development in the field of drug conjugates; Research and development in the pharmaceutical and biotechnology fields; Research and development services in the field of antibodies; Research in the field of chemistry; Scientific research for medical purposes in the area of cancerous diseases; Scientific research in the nature of conducting clinical trials for others; Technology research in the field of pharmaceutical preparations and medical instruments; Testing of chemicals; Testing of cosmetics; Testing of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
29 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/14/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/12/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/11/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/19/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/19/2024
ALIE
ASSIGNED TO LIE
03/19/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/31/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/20/2023
GNRT
NON-FINAL ACTION E-MAILED
09/20/2023
CNRT
SU - NON-FINAL ACTION - WRITTEN
09/20/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/28/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/28/2023
IUAF
USE AMENDMENT FILED
08/22/2023
EISU
TEAS STATEMENT OF USE RECEIVED
08/22/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/08/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/13/2023
PUBO
PUBLISHED FOR OPPOSITION
06/13/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/24/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/08/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/20/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/20/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/20/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/31/2022
GNRT
NON-FINAL ACTION E-MAILED
10/31/2022
CNRT
NON-FINAL ACTION WRITTEN
10/31/2022
DOCK
ASSIGNED TO EXAMINER
10/28/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/26/2022
NWAP
NEW APPLICATION ENTERED
01/24/2022
Continuous trademark protection
Get notified about every new filing that threatens MEDILINK or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.